Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
Association between Immune Traits and Neurodevelopmental Disorders: A Two-Sample Mendelian Randomization Study
2532 Pages Posted: 22 Dec 2023
More...Abstract
Background: One of the main causes of health-related issues in children is neurodevelopmental disorders (NDDs), which include attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and Tourette syndrome (TS). Nonetheless, there is relatively little prior research looking at the link between immunological inflammation and NDDs. Our work uses a two-sample Mendelian Randomization (MR) approach to provide a thorough evaluation of the causal effects of immune traits on ADHD, ASD, and TS.
Methods: As exposures, 731 immunological traits' genetic associations were chosen, and the outcomes were genome-wide association data for ADHD, ASD, and TS. The inverse-variance weighted (IVW), weighted median (WM), and MR-Egger methods were used to conduct MR analysis. The results' robustness, heterogeneity, and horizontal pleiotropy were confirmed using extensive sensitivity analysis.
Findings: With single-nucleotide polymorphisms serving as instruments and false discovery rate (FDR) correction applied, the study found that significantly higher expression of CD62L on CD62L+ myeloid DC (IVW, OR: 0.926, 95% CI 0.896~0.958, P = 9.42×10–6, FDR = 0.007) and suggestively higher absolute cell count (AC) of CD28+ DN (CD4-CD8-) (IVW, OR: 0.852, 95% CI = 0.780 ~ 0.932, P-value = 4.65 × 10-4, FDR = 0.170) was associated with a lower risk of ADHD. There was no pleiotropy, and the causal relationships were strong according to sensitivity, leave-one-out, and MR-Steiger directionality tests. For ASD and TS, no substantial and suggestive risk immune feature was found.
Interpretations: The results of the study lend credence to the theory that deficiency in CD62L on CD62L+ myeloid DC and CD28+ DN (CD4-CD8) AC may contribute to the onset of ADHD.
Funding: This work was supported by the National Natural Science Foundation of China (No. 82274576) and Traditional Chinese Medicine Inheritance and Development Project of Shanghai Medical Innovation & Development Foundation (No. WLJH2021ZYMZY019).
Declaration of Interest: All authors did not disclose conflicts of interest and all authors' declarations were consistent with those declared in the ICMJE Conflict of Interest Form.
Keywords: Immune trait, Autism spectrum disorder, Attention-deficit hyperactivity disorder, Tourette syndrome, MR analysis, CD62L, CD28
Suggested Citation: Suggested Citation